The document is a program agenda for the 2010 Pharmaceutical Leadership Summit taking place on June 25-26, 2010 in India. It outlines the schedule, topics, and speakers for the two-day event. Some of the key speakers and topics included are Tapan Ray discussing Obama's healthcare policy and its implications for India, various government officials, discussions on diversification and expansion in the pharmaceutical industry, the future of medical representatives, competing intelligently in turbulent times, and challenges for mid-sized pharmaceutical companies in building brands. The summit aimed to provide insights from top pharmaceutical companies and discuss important issues and strategies for industry leaders.

1. &
THE MAGAZINE FOR THE PHARMA LEADERS
2010
Friday, Saturday,25th & 26th June,2010, @
listen to the Policy Makers
Shri Ashok Chavan
Hon'ble Chief Minister
Government of Maharastra
Shri Srikant Jena
Hon'ble Union Minister of State for
Chemicals & Fertilizers, GOI
“LIMITLESS
LEADERSHIP” Shri Sanjay Nirupam
Hon'ble Member of Parliament
BRINGING TODAY, Government of India
TOMORROW, Dr Surinder Singh,DCGI
Ministry of Health & Family Affairs
&BEYOND Government of India
Commissioner,
PLAN NOW TO ATTENDTHE NATION’S FDA
Govt of Maharastra
BIGGEST EVENT
AND HEAR FROM FOREMOST Great content and speakers
PHARMA LEADERS Details inside
Insights from 40 of the
Top 100 Companies
Early Bird
Register before
7th June 2010
SUMMIT PARTNERS
HOSPITALITY PARTNER LEADERSHIP PARTNER KNOWLEDGE PARTNER PRINTING & PACKAGING
PARTNER

2. The only Summit
you need
Dear 1 / The Speakers
5 VP insights in addition to a host of expert speakers including 60 of
Colleague... top 100 big pharma & Biotech companies. You will proft from their
vision and take away powerful new strategies and solutions to give
fresh impetus to the way you tackle the challenges you face.
2 / The Networking
During the 18+ hours of dedicated networking, you’ll rub shoulders
New Faces for a New Pharma with the sharpest minds in marketing. No other event can provide you
with 2 days of business focused networking with some of the most
When talking about pharmaceutical leadership, infuential people in your field.
“transformational” is the descriptor of choice. With the
regulatory landscape evolving rapidly, traditional pharma
cocompanies taking the plunge into biotechnology and specialty 3 / The Topics
medicine, and the lifespan of products shrinking, leaders are We have thoroughly researched this area in a bid to uncover the
needed who can push changes in their organizations and within hottest topics specifc to people in your position. Senior marketing and
the pharmaceutical industry. To determine who are today's brand executives from all top 60 pharma Companies
executives on the rise, Pharmaceutical Leadership Summit
2010 sought the agents of change within the industry, the 4 / The Case Studies
executives who are helping to take their companies in new and Learn through a proven formulary of marketing examples, with
different directions. take away best practice techniques. No other event can deliver such
knowledgeable insights and answers to key challenges you face.
Agents of change are appearing throughout organizations.
Starting at the back of the value chain are the research and A glimpse of dazzling and scintillating award evening
development transformers, who are taking an accelerated,
disease-centric approach to R&D versus a therapeutic area
approach. Further up are the commercial transformers,
changing their organizations' approach to sales and marketing.
And then there are the medical transformers, who are focused
on more effectively moving drugs from the late stages of clinical
development to the patient.On the commercial front, a trend can
be seen among the industry's executives on the rise. These
individuals acting as agents of change have all been brought in
from outside the company with a clear charge to transform the
business. In some cases, these companies are clearly looking
to organize around key specialty pharma business units.
Pharmaceutical executives are well aware that commercial
strategies of the last decade are losing effectiveness. At the
root of the problem is a profitability- Under the changed scenario,3rd Annual Pharmaceutical
draining commercial cost basis, which Leadership Summit 2010 will dwell upon many more issues by
results from a sales model that is often industry veterans.....on topics of great importance. I urge you to
overly focused on the primary-care attend the high profile event.
physician. The short-term solution –
Share your thoughts how best I could help you at
cutting back on field sales forces – has
taken companies about as far as it can. satya.brahma@pharmaleaders.co.in
Pharmaceutical companies urgently need
Looking forward to see you...
a new commercial approach that will
either reduce their investment in the Satya Brahma
commodity segment or shift it to other Chairman
segments that will deliver better returns. Pharmaceutical Leadership Summit 2010
Additionally, to achieve meaningful
change, companies will have to rethink
not only how they bring their products to
market, but also what they bring to the
www.pharmaleaders.co.in
market.

3. DAY ONE..... World Class Speakers
at a glance
PROGRAM AGENDA
DAY 1 (Friday 25th June 2010)
08:30 – 09:15 AM Registration & Refreshments
General Session: Moderator : S. Krishnakumar : Head – Corporate Business Devlopment, Warnbury Ltd
09:15-09:25 AM Opening Address – Satya Brahma, Editor-In-Chief, Pharma Leaders.
Release of an exclusive white paper on Booming Pharma Industry – The Road Ahead 2015.
09:25-09:55 AM Welcome Address:
Commissioner, FDA, Govt of Maharastra
09:55 – 10.25 AM Keynote Address :
Tapan Ray, Director General, OPPI.
Obama’s Healthcare policy - An Indian Perspective of its implications.
The Patient Protection and Affordable Care Act ,a federal statute that was signed into law in the United States by President Barack
Obama on March 23, 2010. Along with the Health Care and Education Reconciliation Act of 2010 (signed into law on March 30, 2010),
the Act is a product of the health care reform agenda of the Democratic 111th Congress and the Obama administration.The law
includes a large number of health-related provisions to take effect over the next four years, including expanding Medicaid eligibility,
subsidizing insurance premiums, providing incentives for businesses to provide health care benefits, prohibiting denial of
coverage/claims based on pre-existing conditions, establishing health insurance exchanges, and support for medical research.
10.25 – 10.55 AM Address By Shri Ashok Chavan,
Hon’ble Chief Minister,
Government of Maharastra.
10.55 – 11.25 AM Address by Shri Srikant Jena,
Hon’ble Union Minister of State for Chemicals & Fertilizers,
Government of India.
11.25 – 11.55 AM Address by Shri Sanjay Nirupam
Hon’ble Member of Parliament,
Government of India.
11.55 – 12.25 PM Keynote Address:
Dr Surinder Singh,DCGI,
Ministry of Health & Family Affairs
11.55 – 12.25 PM Keynote Address:
Dr Kamal Sharma, MD, Lupin Ltd.
Destination 2010 - Diversification, Expansion & Ambitions
12.25 -12.55 PM Dr Ramakant Panda, Vice-Chairman, Asian Heart Institute.
Modern Day Practioners : Aims & Aspirations
12.55-01.25 PM Keynote Address:
Leadership in the Face of Change...Mastering Resiliency : The Road Ahead.
Kewal Handa : Managing Director – Pfizer Ltd
01.25 -02.25 PM Networking & Luncheon at Majestic Hall

4. 02.25 – 02.55 PM Keynote:
Preventive Personalised Healthcare - The way Forward"
Dr. Villoo Morawala-Patell, Founder CEO & MD. Avesthagen Limited.
Most Indian biotech companies survive by doing reverse engineering or contract work but Morawala-Patell set out to give Avesthagen a
strong focus in innovative R&D in diverse areas such as bioAgriculture, bioNutrition, biopharmaceuticals and drug discovery. And now
she has split these four strategic business units as four independent profit and loss (P&L) entities, so that it can take care of its own
financial requirements. With a fifth of small European biopharmaceutical companies possibly facing bankruptcy by the end of the year, the
fear is that many Indian biotech companies could also face the same fate, thanks to the liquidity and credit crisis. The presentation will
dwell on about the ripple effect on the Indian biotech
02.55 – 03.25 PM Emergence of Biotech Entrepreneurs : Leadership role in 2010
Dr Krishna Ella, CMD, Bharat Biotech International Ltd.
03:25-03:55 PM Bulk Drug & API’s : Challenges & Opportunities Ahead!!!
Dr.B.P. S Reddy, Chairman, Hetro Drugs Ltd
The Active Pharmaceutical Ingredient (API) industry in India is gearing up to grab the fast growing global market opportunities through
quality manufacturing and R&D activities even as global pharma majors are looking towards low cost quality manufacturing centres in the
emerging nations.According to the latest figures from the Bulk Drug Manufacturers Association (BDMA), the size of the API industry is
about Rs 32000 crore to Rs 35000 crore ($6.61 billion to $7.23 billion) of the total Rs 78000 crore ($16.12 billion) Indian pharma industry.
Out of the total API business, almost Rs 15000 crore to Rs 18000 crore ($3.1 billion to $3.7 billion) comes from exports.
03:55-04.25 PM Medical Representatives :Future Leaders of Robust Indian Pharma Sector.
Mr.Deepak Naik, Managing Director, Eisai Pharma Ltd.
04.25-05.00 PM Break – Refreshments
05.00 – 05.30 PM Is the Block-buster Molecule outdated??
Dr R.B.Smarta, Managing Direrctor, Interlink Consultancy Pvt Ltd
This panel discussion will bring together leaders in the drug delivery device market with leaders in the drug development market to
discuss how alliances can bring sustainable competitive advantage to both groups and the role Leaders has in the selection of a partner.
05:30-06:00 PM The Leadership Journey: Creating and Developing Leadership cramp models
in Pharma Industries.
Pravin Iyer, CEO, Medreich Ltd
When does leadership matter most? How can you use your personal leadership skills to tackle organizational challenges?
How can you inspire employees to assume more responsibility for leading themselves? With the simultaneous rise in
mergers and acquisitions and the creation of start ups and more autonomous divisions within established companies, the
demand for exceptional leadership has never been greater. Cramp Model Analysis..
06:00-06:30 PM Networking & Refreshments in Exhibition Hall
06:30-07:00 PM Venket Jasti, MD, Suven Life Sciences Ltd.
How Pharma Leaders Can Survive and Thrive In Turbulent Times by Embracing Innovation?
Turbulent economic times create new opportunities and threats for CI and BI professionals. This presentation will share field research
findings regarding traumatic changes under way in the global bio-pharma and medical device sectors – with case examples illuminating
how savvy Pharma Leaders and BI pros survive and thrive by aligning organizational intelligence with rapidly changing leadership teams,
organizational structures, business units, brands and priorities. .
07.00 –07.30 PM Anand Desai Managing Partner DSK Legal
Competitive Intelligence and the Law: Myths and Facts
07:30-08:30 PM Tea & Cofee Break
08.30 –09.15 PM: PANEL DISCUSSION LIVE ON ET NOW :
Moderator : Arnab Goswamy : Editor-In-Chief TIMES NOW
Kewal Handa :MD, Pfizer Ltd
Suresh Kare :CMD, Indoco Remedies Ltd.
Pravin Iyer, CEO, Medreich group
Dr Kamal Sharma, MD, Lupin Ltd.
Sanjay Nirupam, Member of Parliament, Govt of India.
Dr Surinder Singh, Drug Controller of India.
Dilip Sanghavi, CMD, Sun Pharmaceuticals Ltd.
Dr Shailesh Iyenger, MD, Aventis Pharma Ltd.
09.15 – Onwards Cocktails & Dinner

5. DAY TWO..... World Class Speakers
at a glance
PROGRAM AGENDA
DAY 2 (Saturday 26th June 2010)
09:15-10:15 Registration & Networking Breakfast in Exhibition Hall
10:15-11:00 How Pharma Leaders Can Survive and Thrive In Turbulent Times??
Turbulent economic times create new opportunities and threats for CI and BI professionals. This presentation will share field
research findings regarding traumatic changes under way in the global bio-pharma and medical device sectors – with case
examples illuminating how savvy Pharma Leaders and BI pros survive and thrive by aligning organizational intelligence with
rapidly changing leadership teams, organizational structures, business units, brands and priorities.
Shailesh Iyenger, MD, Aventis Pharma Ltd.
11:00-12:00 Keynote Address : Is the Indian health care delivery system ready for change?
India needs a continuously improving, self-regulating, patient-centred healthcare delivery system. If India is to improve its
healthcare delivery mechanism and become a preferred healthcare destination, as pronounced in the National Health Policy,
a necessary prerequisite is the setting up of internationally acceptable and highly credible accreditation systems. McKinsey
study predicts that in 2012, the healthcare market may well be estimated at US$45bn. Private healthcare is expected to
account for 75 percent of this spending.
Malvinder Mohan Singh, Group Chairman, Fortis Healthcare & Parkway Holdings
12.00 –12.30 Leadership Lessons from India: The India Way of Leading Business
Narayan Gad, CEO - Formulations, Panacea Biotech Ltd.
We have come to believe that undergirding the rapid expansion of the Indian economy and the stunning growth
of many of its largest companies is an innovative and exportable way of doing business. To understand the
Indian way of doing business where the critical decisions of the nation's most important companies are made.
12.30 –01.00 Emergence of Social Devlopment Sector : Corporates need to focus more on CSR? – A
Wockhardt Foundation case study: Huzaifa Khorakiwala, CEO, Wockhardt Foundation &
Executive Director, Wockhardt Ltd
01.00 – 02.00PM Lunch – Break
2.00 – 2.30 PM Globalisation of alternative therapy market-Challenges and opportunities
Mr. Pulin Shroff, MD, Charak Pharma ltd.
02.30 – 03.00 Education through Mid-day meal programs - An overview of The Akshayapatra Foundation
Chanchalapati Dasa, Vice Chairman, The Akshayapatra Foundation
03.00 – 03.30 Building Pharma Brands : Challenges & Oppourtunities of Mid-Sized Companies.
"Today, the markets have evolved with time. In countries like Russia, consumers are ready to pay a higher cost
for quality and there are international competitors who are fighting for a share of these growing markets. The
global meltdown could negatively impact Indian pharma exports but "good relationships with the target audience
help to sustain longer in the markets.Marketing of pharma products calls for a strong field-force network
complimented with a robust supply-chain. A growing product portfolio is the key to beat competition and this will
ensure a constant flow of income into the business.
J.P.N.Singh, Director, Galpha Labs Ltd
03.30 – 04.15 Destination 2010
Diversification, Expansion & Ambitions
Anuj Saxena, Managing Director, Elder Healthcare Ltd.
The days when the Indian pharmaceutical industry was synonymous with cheap generic drug production are passing. While
generics continue to play a major part in the industry’s success, many companies have started down the long road of drug
discovery and branded product development.

6. 04:15-04:45 100 Prescriptions for 1 Lac : Is the era of ethical marketing over?
Ruth D’ souza, Executive Director, Interlink Marketing Consultancy Pvt Ltd.
In what seems to be a case of giving the fox the job of guarding the henhouse, the government has decided to
curb the practice of bribing doctors for promoting drugs by allowing pharmaceutical companies to self-regulate
rather than have a legislation to tackle the menace. This is despite the fact that more than a quarter of the
members of the Organisation of Pharmaceutical Producers of India (OPPI) an association mainly of
multinationals which is estimated to account for 70% of the drug market in India are subsidiaries of companies
that have been penalised in the US for illegally promoting various drugs through inducements for doctors. Of
the 53 pharma members of the OPPI, over 25% have figured in such cases in the US. This is despite the fact
that Pharmaceutical Research and Manufacturers of America (PhRMA), which includes many of these
penalised companies, already has a voluntary Code on Interactions with Health Professionals which explicitly
prohibits members from giving illegal inducements to doctors to get them to prescribe their products.
04.45 – 05.15 Can we face the Heat of Globalization ?
Ram Prasad Reddy, Chairman, Aurobindo Pharma Ltd
05.15 – 05.45 Mr Ramesh Adige, Global Director – Communications , Ranbaxy Ltd.
Is India marching ahead towards social enterprenuership
05.45 – 06.15 Networking & Refreshments in Exhibition Hall
06.15 – 06.45 Retail Pharmacy Market in India :
Suneeta Reddy, Group CFO, Appolo Group.
The number of present pharmacies in the country, estimated over 5 lacks, has to be looked from a practical
positive angle. They too have a role to play - to make the medicines available to the common man at affordable
cost.They have survived amidst odds and unhealthy competition due to irrational grant of too many sales
licences, unmindful of the need. The industry is growing at 41% per annum and expected to reach INR 432 bn
by 2011. Growth in this sector is being propelled by increase in healthcare spending, growth in pharma sector &
organized pharma retail, changing disease profile of India, consumer attitudes, attractive margins and growth
in OTC segment.
6.45 - 7-15 The Essence of living- perspectives from dietry guidelines and nutritional suppliments
Dr Anjali Mukharjee, noted Nutritionist
07.15 – 07.45 Authorised Generics-Threats or opportunities
Keynote Address : Satish Reddy, CEO & MD, Dr Reddy’s Labs Ltd.
With low-cost manufacturing, high-quality research and manufacturing facilities and educated personnel, the
Indian pharmaceutical industry presents both a competitive threat and partner opportunities. India is the
world’s fourth largest producer of pharmaceuticals by volume, accounting for around 8% of global production.
In value terms, production accounts for around 1.5% of the world total. The Indian pharmaceutical industry
directly employs around 500,000 people and is highly fragmented. While there are around 270 large R&D
based pharmaceutical companies in India, including multinationals, government-owned and private
companies, there are also around 5,600 smaller licensed generics manufacturers, although in reality only
around 3,000 companies are involved in pharmaceutical production. Most small firms do not have their own
production facilities, but operate using the spare capacity of other drug manufacturers.
07:45-08:45.: Vote of Thanks : Satya Brahma, Editor-In-Chief, Pharma Leaders,
followed by Pharmaceutical Leadership Awards
8.45 onwards Cocktail & Dinner with a grand Gala evening Surprise
THE DOYENS OF THESE SPEAKERS WILL
BRAINSTORM AT PHARMACEUTICAL
LEADERSHIP SUMMIT 2010
A power packed audience watching the proceedings in full flow

7. Don’t miss a single presentation!
Reserve your place today at pharmaleaders@pharmaleaders.co.in
Reasons to attend
Cutting edge Pipeline Strategy workshop
350 Senior executives
60 Thought-leading speakers Summit White Paper
5 EASY STEPS
18 Hours networking Exclusive Speakers presentation material TO REGISTER
Meet 350 senior level marketing executives CALL +91 22 2666656
Breakdown of last year’ FAX +91 22 2666463
Head of Marketing / Marketing Director EMAIL pharmaleaders
CEO / Managing Director / General Manager @pharmaleaders.co.in
Brand Manager / Product Manager CELL +91 9920246286
Commercial & Marketing Manager +91 8147710295
Consultants / Solution Providers
ONLINE www.pharmaleaders.co.in
Press
MEDIA PARTNERS BIOTECH MAGAZINE PARTNER KNOWLEDGE PARTNER CREATIVE DESIGN PARTNER PRINTING & PACKAGING PARTNER HEALTHCARE MEDIA PARTNER
GIFT PARTNER RADIO PARTNER ONLINE PARTNER PHARMA HR PARTNER
IN ASSOCIATION WITH BROUGHT TO PHARMA CSR MIDDAY MEAL
YOU BY PARTNER PARTNER
www.indioppi.com www.idma.org www.ipa.org www.pharmexcil.com www.bdma.com www.integrralmedia.com www.wockhardtfoundtion.org www.akshayapatra.org

8. Plan now to participate industry’s much
awaited leadership awards
THE MAGAZINE FOR THE PHARMA LEADERS
presents
PHARMACEUTICAL
Saturday,26th June,2010,
LEADERSHIP
AWARDS 2010
Majestic Hall,
Hotel Intercontinental,
Mumbai ,India.
Honouring Excellence in Healthcare & Pharmaceuticals
“LIMITLESS LEADERSHIP”
BRINGING TODAY,TOMORROW & BEYOND

9. VOTE ONLINE YOUR FAVOURITE LEADERS
@ www.pharmaleaders.co.in
The pharma industry
is facing some tough
times—and the old
way of doing things
just won't work. So
just who are the new
leaders steering the
industry though its
most difficult
challenges? Which
executives are
revamping the
industry—through
pure innovation—to Award Categories – 2010.
remake it for the 21st
century?
1. Brand of The Year.
2. Pharma Professional of the Year.
An independent 3. Businessman of the year
panel of prominent
society and industry 4. Company of the year
leaders will judge the 5. Best Company in R&D Excellence.
awards. Winners will
be selected prior to 6. Dynamic Entrepreneur of The Year.
the WIL India Awards 7. Emerging Company of The Year.
ceremony. Judging
will be based on 8. India's Most Admired Pharma Company.
information provided 9. Research Scientist of The Year.
by the nominees.
Finalists will be 10. Excellence in Bulk Drugs & Exports
notified in advance - 11. Hottest Exports Company of the Year.
in writing. The final
winners will be 12. Company of the year ( SME)
announced at the 13. India's Most Watched Company of the year.
awards evening, on
Saturday, 26th June, 14. Excellence in Nutrition & Nutraceuticals
15. Best Product Launch of the year.
16. Excellence in Pharmacy & Community Healthcare profession.
17. India's Most Advanced Manufacturing Company.
18. OTC Company of the year.
19. Businesswoman of the year.
20. Lifetime Achievement Award 2010.
Flashback memorable moments of Pharmaceutical Leadership Awards

10. Pharmaceutical Leadership
Summit & Awards redefined
PHARMACEUTICAL
LEADERSHIP 2010
AWARDS 2010 “LIMITLESS LEADERSHIP”
BRINGING TODAY,
Honouring Excellence in Healthcare & Pharmaceuticals TOMORROW & BEYOND
SUMMIT PARTNERS
HOSPITALITY PARTNER LEADERSHIP PARTNER KNOWLEDGE PARTNER PRINTING & PACKAGING
PARTNER
MEDIA PARTNERS BIOTECH MAGAZINE PARTNER KNOWLEDGE PARTNER CREATIVE DESIGN PARTNER PRINTING & PACKAGING PARTNER HEALTHCARE MEDIA PARTNER
PHARMA HR PARTNER
GIFT PARTNER RADIO PARTNER ONLINE PARTNER
SUMMIT AWARD PARTNER
IN ASSOCIATION WITH BROUGHT TO PHARMA CSR MIDDAY MEAL
YOU BY PARTNER PARTNER
www.indioppi.com www.idma.org www.ipa.org www.pharmexcil.com www.bdma.com www.integrralmedia.com www.wockhardtfoundtion.org www.akshayapatra.org
Summit Secretariat: CALL +91 22 2666656
Speak to our friendly event specialists
for your tailor made requirements :
Integral Media Pvt Ltd.
3A, Central Plaza, 166 C.S.T.
FAX +91 22 2666463 Debashish Chakrabartty
+91 8147710295 +91 9590355290
Road,Kalina, Santacruz (E),Mumbai, EMAIL pharmaleaders@pharmaleaders.co.in
Maharastra,Pin : 400 098, India. Panduranga Rao Patil
ONLINE www.pharmaleaders.co.in +91 9920246286, +91 7738741178
Fax: 91-22-2666 6463